SINGLETON J MATTHEW
SEC CIK 1243514 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | Dir | 12.7K | — | $4.58M | 11 | 2024-08-14 | 2026-01-02 |
Most active insiders at VKTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lian Brian | Pres, CEO, Dir | — | $14.01M |
| 2 | ZANTE GREG | CFO | — | $2.82M |
| 3 | Mancini Marianna | COO | — | $2.73M |
| 4 | Rowland Charles A Jr | Dir | — | $2.13M |
| 5 | FOEHR MATTHEW W | Dir | — | $561.8K |
| 6 | Aubuchon Neil William | Chief Commercial Off | $149.9K | — |
| 7 | Kelly-Gemmell Dorothy Elizabeth | Dir | — | — |
| 8 | Rouan Sarah Kathryn | Dir | — | — |
| 9 | MACARTNEY LAWSON | Dir | — | — |
| 10 | SINGLETON J MATTHEW | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | A - Grant | $0.00 | +3,150 | 12.7K | +33% | $0 |
| DT | 2024-10-25 | 2024-10-25 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | S - Sale+OE | $79.50 | -16.0K | 9,500 | -63% | -$1.27M |
| DT | 2024-10-25 | 2024-10-25 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | M - OptEx | $4.48 | +16.0K | 25.5K | +168% | +$71.7K |
| DT | 2024-09-20 | 2024-09-20 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | M - OptEx | $1.19 | +10.3K | 19.8K | +108% | +$12.3K |
| DT | 2024-09-20 | 2024-09-20 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | S - Sale+OE | $69.50 | -10.3K | 9,500 | -52% | -$715.9K |
| DT | 2024-08-22 | 2024-08-21 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | M - OptEx | $1.19 | +5,700 | 15.2K | +60% | +$6,783 |
| DT | 2024-08-22 | 2024-08-21 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | S - Sale+OE | $69.72 | -5,700 | 9,500 | -38% | -$397.4K |
| DT | 2024-08-19 | 2024-08-19 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | M - OptEx | $3.33 | +16.0K | 25.5K | +168% | +$53.3K |
| DMT | 2024-08-19 | 2024-08-19 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | S - Sale+OE | $62.22 | -16.0K | 23.0K | -41% | -$995.4K |
| DMT | 2024-08-14 | 2024-08-14 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | S - Sale+OE | $57.53 | -20.8K | 9,500 | -69% | -$1.20M |
| DT | 2024-08-14 | 2024-08-14 | VKTX | Viking Therapeutics, Inc. | SINGLETON J MATTHEW | Dir | M - OptEx | $8.00 | +20.8K | 30.3K | +219% | +$166.3K |
Purchase Sale Sale after option exercise All abbreviations